David Robinson is Vice President at Kantar Health in the
Clinical & Scientific Assessment Group. David is responsible
for Global Epidemiology Services across established markets and
emerging markets. Epidemiology expertise within his team spans
more than 190 indications, with a dedicated focus on Oncology.
David gained pharmaceutical industry and medical products
experience with Sanofi Pharmaceuticals, Bock Pharmacal, Marion
Merrell Dow, and the Analytab Products division of Sherwood
Medical. He has a strong scientific and marketing background,
particularly with infectious diseases and antibiotics, and he has
extensive experience in managed care and best practices.
He currently serves as a member of the Institutional Review
Board at St. Louis University School of Medicine and is an Adjunct
Professor at the St. Louis College of Pharmacy. David earned a B.S.
in Biology from the University of Delaware and an M.S. in Clinical
Microbiology from Temple University School of Medicine.